EMEA (Europe, Middle East and Africa) Glucagon Like Peptide-1 (GLP-1) Agonists Market Report 2017

December 2017 | 100 pages | ID: EDFCB5521D6EN
QYResearch

Abstracts

In this report, the EMEA Glucagon Like Peptide-1 (GLP-1) Agonists market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Glucagon Like Peptide-1 (GLP-1) Agonists for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Glucagon Like Peptide-1 (GLP-1) Agonists market competition by top manufacturers/players, with Glucagon Like Peptide-1 (GLP-1) Agonists sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novo Nordisk
• AstraZeneca
• Eli Lily
• GSK
• Sanofi
• Bristol-Myers Squibb
• Amylin

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Exenatied
• Liraglutide
• Lixisenatide
• Abliglutide
• Dulaglutide

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Glucagon Like Peptide-1 (GLP-1) Agonists Market Report 2017

1 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS OVERVIEW

1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Classification of Glucagon Like Peptide-1 (GLP-1) Agonists
  1.2.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Exenatied
  1.2.4 Liraglutide
  1.2.5 Lixisenatide
  1.2.6 Abliglutide
  1.2.7 Dulaglutide
1.3 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Market by Application/End Users
  1.3.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Market by Region
  1.4.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Glucagon Like Peptide-1 (GLP-1) Agonists (2012-2022)
  1.5.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2022)

2 EMEA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Market Competition by Players/Manufacturers
  2.1.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price by Players (2012-2017)
2.2 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists (Volume and Value) by Type/Product Category
  2.2.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price by Type (2012-2017)
2.3 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists (Volume) by Application
2.4 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists (Volume and Value) by Region
  2.4.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price by Region (2012-2017)

3 EUROPE GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Value (2012-2017)
  3.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
3.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type
3.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application
3.4 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume by Countries (2012-2017)
  3.4.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Countries (2012-2017)
  3.4.3 Germany Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  3.4.4 France Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  3.4.5 UK Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  3.4.6 Russia Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  3.4.7 Italy Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)

4 MIDDLE EAST GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Value (2012-2017)
  4.1.1 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
4.2 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type
4.3 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application
4.4 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  4.4.4 Israel Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  4.4.5 UAE Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  4.4.6 Iran Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)

5 AFRICA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Value (2012-2017)
  5.1.1 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
5.2 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type
5.3 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Market Share by Application
5.4 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume by Countries (2012-2017)
  5.4.2 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Countries (2012-2017)
  5.4.3 South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2012-2017)

6 EMEA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lily
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GSK
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Amylin
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Glucagon Like Peptide-1 (GLP-1) Agonists Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURING COST ANALYSIS

7.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET FORECAST (2017-2022)

11.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Price and Trend Forecast (2017-2022)
11.2 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Type (2017-2022)
11.7 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Type (Product Category) in 2016
Figure Exenatied Product Picture
Figure Liraglutide Product Picture
Figure Lixisenatide Product Picture
Figure Abliglutide Product Picture
Figure Dulaglutide Product Picture
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Million USD) by Region (2012-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Status and Forecast by Countries
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume and Growth Rate (2012-2022)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Players (2012-2017)
Figure 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Players
Figure 2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Players
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Players (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Players (2012-2017)
Table 2016 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Players
Table 2017 EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Players
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2012-2017)
Figure Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2012-2017)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2016
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Application (2012-2017)
Figure Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application (2012-2017)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2016
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Region (2012-2017)
Figure Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Region (2012-2017)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in 2016
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Region (2012-2017)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Regions in 2016
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type in 2016
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Application (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Application in 2016
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Countries (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries in 2016
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Countries (2012-2017)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2012-2017)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries in 2016
Figure Germany Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure France Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure UK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2012-2017)
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type (2012-2017)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type (2012-2017)
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Applications (2012-2017)
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Applications (2012-2017)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2016
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume Market Share by Countries in 2016
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Countries (2012-2017)
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2012-2017)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2012-2017)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries in 2016
Figure Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2012-2017)
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2012-2017)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2012-2017)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2016
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2012-2017)
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2012-2017)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2012-2017)
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Volume (K Units) by Countries (2012-2017)
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries (2012-2017)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries (2012-2017)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Countries in 2016
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) by Countries (2012-2017)
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2012-2017)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries (2012-2017)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Countries in 2016
Figure South Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Basic Information List
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Basic Information List
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share in EMEA (2012-2017)
Table Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Basic Information List
Table Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in EMEA (2012-2017)
Figure Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share in EMEA (2012-2017)
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Basic Information List
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in EMEA (2012-2017)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share in EMEA (2012-2017)
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Basic Information List
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in EMEA (2012-2017)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Basic Information List
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share in EMEA (2012-2017)
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Basic Information List
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate (2012-2017)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in EMEA (2012-2017)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
Table Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table Major Buyers of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Distributors/Traders List
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Region (2017-2022)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Region (2017-2022)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Countries (2017-2022)
Table Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Countries (2017-2022)
Table Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Type (2017-2022)
Table EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources